References
- Lavie CJ, Gau GT, Squires RW et al. Management of lipids in primary and secondary prevention of cardiovascular diseases. Mayo Clin Proc 1988: 63(6): 605–21
- The Expert Panel. Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Arch Intern Med 1988: 148(1): 36–69
- O'Keefe JH Jr, Lavie CJ, O'Keefe JO. Dietary prevention of coronary artery disease: how to help patients modify eating habits and reduce cholesterol. Postgrad Med 1989: 85(6): 243–61
- Castelli WP. Low HDL cholesterol as a predictor of CHD risk. Internal Medicine for the Specialist 1989: Sep: 6–13
- Gordon DJ, Probsifield JL, Garrison RJ, et al. High-density lipoprotein cholesterol and cardiovascular disease: four prospective American studies. Circulation 1989: 79(1): 8–15
- The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease. JAMA 1984: 251(3): 351–64
- Frick MH, Elo O, Haapa K, et al. Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease. N Engl J Med 1987: 317(20): 1237–45
- Manninen V, Elo MO, Frick MH. et al. Lipid alterations and decline in the incidence of coronary heart disease in the Helsinki Heart Study. JAMA 1988: 260(5): 641–51
- Coronary Drug Project Research Group. Natural history of myocardial infarction in the Coronary Drug Project: long-term prognostic importance of serum lipid levels. Am J Cardiol 1978: 42: 489–98
- Canner PL, Beige KG, Wenger NK, et al. Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin. J Am Coll Cardiol 1986: 8(6): 1245–55
- Arntzenius AC, Kromhout D, Barth JD, et al. Diet, lipoproteins, and the progression of coronary atherosclerosis: the Leiden Intervention Trial. N Engl J Med 1985: 312(13): 805–11
- Levy RI, Brensike JF, Epstein SE, et al. The influence of changes in lipid values induced by cholestyramine and diet on progression of coronary artery disease: results of NHLBI Type II Coronary Intervention Study. Circulation 1984: 69(2): 325–37
- Blankenhorn DH, Nessim SA, Johnson RL, et al. Beneficial effects of combined colestipol-niacin therapy on coronary atherosclerosis and coronary venous bypass grafts. JAMA 1987; 257(23): 3233–40 [erratum, JAMA 1988: 259(18): 2698]
- Brown BG, Lin JT, Schader SM, et al. Niacin or lovastatin, combined with colestipol, regress coronary atherosclerosis and prevent clinical events in men with elevated apolipoprotein B. (Abstr) Circulation 1989: 80(4): II–266
- Anderson AJ, Schuchard GH, Battiola RJ, et al. The prevalence of low HDL cholesterol levels in three groups of patients with cholesterol less than 200mg/dL. (Abstr) Circulation 1989: 80(4): II–511
- Romm PA, Green CE, Reagan K, et al. The importance of HDL in the relationship between lipid values and coronary disease. (Abstr) Circulation 1989: 80(4): II–511
- Ginsburg GS, Safran L, Pasternak RC. National Cholesterol Education Program guidelines: the impact of missing HDL (Abstr) Circulation 1988: 78(4): II–382
- Miller M, Mead L, Kwiterovich PO, et al. Lipid abnormalities in coronary disease patients with “desirable” cholesterol levels: should we screen all CAD patients for low HDL levels? (Abstr) Circulation 1988: 78(4): II–383
- Wones RG, Kerman KM, Stein EA, et al. Characteristics of high-HDL referral errors from public cholesterol screening. (Abstr) Circulation 1988: 78(4): II–382
- Romm PA, Green CE, Reagan K, et al. Relationship between lipid values and anatomic coronary artery disease in patients with total cholesterol below 200 mg/dL. (Abstr) J Am Coll Cardiol 1990: 15(2): 155A
- Grundy SM. Comparison of monounsaturated fatty acids and carbohydrates for lowering plasma cholesterol. N Engl J Med 1986: 314(12): 745–8
- Squires RW, Gau GT, Kottke BA, et al. The effects of nicotinic acid on blood lipids in patients with low HDL-cholesterol and normal total cholesterol levels. (Abstr) J Cardiopulm Rehabil 1989: 9(10): 414
- Vega GL, Grundy SM. Comparison of lovastatin and gemfibrozil in normolipidemic patients with hypoalphalipoproteinemia. JAMA 1989: 262(22): 3148–53